Data / Form D filings / GALECTIN THERAPEUTICS INC
GALECTIN THERAPEUTICS INC: Form D filings
GALECTIN THERAPEUTICS INC, a pharmaceuticals company in Norcross, GA, filed 4 Form D notices with the SEC between 2011 and 2017. The latest, on January 6, 2017, reports $3 million sold of a $10 million offering to 5 investors.
Find out what GALECTIN THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, Norcross, GA, 30071
- Phone
- (678) 620-3186
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1133416
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 6, 2017 | New notice | $10,000,000 | $3,000,000 | $7,000,000 | 5 | Dec 22, 2016 | sec.gov |
| Sep 28, 2016 | New notice | $12,000,000 | $1,500,000 | $10,500,000 | 1 | Sep 22, 2016 | sec.gov |
| Dec 21, 2015 | New notice | Indefinite | $0 | Indefinite | 6 | Nov 25, 2015 | sec.gov |
| Jan 12, 2011 | New notice | Indefinite | $2,250,000 | Indefinite | 22 | Dec 30, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin D Freeman | Director | |
| Gilbert S Omenn | Director | |
| Harold H. Shlevin | Executive Officer | |
| Theodore H. Zuconni | Director | |
| Steven G. Prelack | Director | |
| Gilbert F Amelio | Director | |
| Marc G. Rubin | Director | |
| James C Czirr | Director | |
| John G. Mauldin | Director | |
| Peter G Traber | Executive Officer, Director | |
| Jack W Callicutt | Executive Officer | |
| Arthur R Greenberg | Director |
Other pharmaceuticals companies in Georgia that filed recently
- Laurentide Therapeutics Inc. $99,999 · Sep 28, 2026
- LifeCyte Innovations, Inc. $1 million · Aug 20, 2026
Every Form D from the week of Jan 2, 2017 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what GALECTIN THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.